Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hannah Bertrand"'
Publikováno v:
HemaSphere, Vol 5, Iss 5, p e565 (2021)
Even after development of the JAK1/JAK2 inhibitor ruxolitinib, myeloproliferative neoplasm (MPN) patients require novel therapeutic options. While ruxolitinib can considerably improve quality of life and prolong survival, it does not modify the natur
Externí odkaz:
https://doaj.org/article/f66e03f2b42847d99e9a14da8384fb4f
Autor:
Andrea Keppler-Hafkemeyer, Christine Greil, Paul R. Wratil, Khalid Shoumariyeh, Marcel Stern, Annika Hafkemeyer, Driti Ashok, Alexandra Hollaus, Gaia Lupoli, Alina Priller, Marie L. Bischof, Gabriele Ihorst, Monika Engelhardt, Reinhard Marks, Jürgen Finke, Hannah Bertrand, Christopher Dächert, Maximilian Muenchhoff, Irina Badell, Florian Emmerich, Hridi Halder, Patricia M. Spaeth, Percy A. Knolle, Ulrike Protzer, Michael von Bergwelt-Baildon, Justus Duyster, Tanja N. Hartmann, Andreas Moosmann, Oliver T. Keppler
Publikováno v:
Nat. Cancer 4, 81–95 (2023)
Individuals with hematologic malignancies are at increased risk for severe coronavirus disease 2019 (COVID-19), yet profound analyses of COVID-19 vaccine-induced immunity are scarce. Here we present an observational study with expanded methodological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7a578dee972e7a71f01fd5c9936e2b2
https://pubmed.ncbi.nlm.nih.gov/36543907
https://pubmed.ncbi.nlm.nih.gov/36543907